These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36194072)

  • 1. A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment.
    Mehta P; Raymond J; Han M; Punjani R; Larson T; Berry JD; Brooks BR; Oskarsson B; Goutman SA; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):230-236. PubMed ID: 36194072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism.
    Mehta P; Raymond J; Han MK; Larson T; Berry JD; Paganoni S; Mitsumoto H; Bedlack RS; Horton DK
    J Med Internet Res; 2021 Dec; 23(12):e28021. PubMed ID: 34878988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.
    Nelson LM; Topol B; Kaye W; Raymond J; Horton DK; Mehta P; Wagner T
    Neuroepidemiology; 2022; 56(2):104-114. PubMed ID: 34929703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National ALS Registry: a recruitment tool for research.
    Malek AM; Stickler DE; Antao VC; Horton DK
    Muscle Nerve; 2014 Nov; 50(5):830-4. PubMed ID: 25111654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    Bryan L; Kaye W; Antao V; Mehta P; Muravov O; Horton DK
    PLoS One; 2016; 11(4):e0153683. PubMed ID: 27124833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.
    Raymond J; Oskarsson B; Mehta P; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):413-420. PubMed ID: 31131638
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017.
    Mehta P; Raymond J; Punjani R; Han M; Larson T; Kaye W; Nelson LM; Topol B; Muravov O; Genson C; Horton DK
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):108-116. PubMed ID: 35422180
    [No Abstract]   [Full Text] [Related]  

  • 10. A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018.
    Raymond J; Berry J; Kasarskis EJ; Larson T; Horton DK; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):211-213. PubMed ID: 37789566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015.
    Mehta P; Kaye W; Raymond J; Punjani R; Larson T; Cohen J; Muravov O; Horton K
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(46):1285-1289. PubMed ID: 30462626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of creating a National ALS Registry using administrative data in the United States.
    Kaye WE; Sanchez M; Wu J
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):433-9. PubMed ID: 24597459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
    Mehta P; Raymond J; Punjani R; Larson T; Han M; Bove F; Horton DK
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):378-382. PubMed ID: 35023792
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.
    Nelson LM; Topol B; Kaye W; Williamson D; Horton DK; Mehta P; Wagner T
    Neuroepidemiology; 2018; 51(3-4):149-157. PubMed ID: 30092573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
    Mehta P; Raymond J; Punjani R; Larson T; Bove F; Kaye W; Nelson LM; Topol B; Han M; Muravov O; Genson C; Davis B; Hicks T; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):220-225. PubMed ID: 34423697
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.
    Bhattacharya R; Harvey RA; Abraham K; Rosen J; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):251-259. PubMed ID: 30892090
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparing for a U.S. National ALS Registry: Lessons from a pilot project in the State of Georgia.
    Benatar M; Wuu J; Usher S; Ward K
    Amyotroph Lateral Scler; 2011 Mar; 12(2):130-5. PubMed ID: 20843169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of population-based controls for ALS cases from the National ALS Registry.
    Bear TM; Malek AM; Foulds A; Rager J; Deperrior SE; Vena JE; Larson TC; Mehta P; Horton DK; Talbott EO
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):395-400. PubMed ID: 33860698
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the completeness of the national ALS registry, United States.
    Kaye WE; Wagner L; Wu R; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):112-117. PubMed ID: 29020837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.